SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Apr 05, 2023	Initial filing by director officer or owner of more than ten percent.	3	0001593968-23-000582.pdf 0001593968-23-000582.rtf 0001593968-23-000582.xls View HTML
Apr 05, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000583.pdf 0001593968-23-000583.rtf 0001593968-23-000583.xls View HTML
Mar 24, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000521.pdf 0001593968-23-000521.rtf 0001593968-23-000521.xls View HTML
Mar 24, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000525.pdf 0001593968-23-000525.rtf 0001593968-23-000525.xls View HTML
Mar 24, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000523.pdf 0001593968-23-000523.rtf 0001593968-23-000523.xls View HTML
Mar 24, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000529.pdf 0001593968-23-000529.rtf 0001593968-23-000529.xls View HTML
Mar 24, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000527.pdf 0001593968-23-000527.rtf 0001593968-23-000527.xls View HTML
Mar 16, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000491.pdf 0001593968-23-000491.rtf 0001593968-23-000491.xls View HTML
Mar 16, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-000492.pdf 0001593968-23-000492.rtf 0001593968-23-000492.xls View HTML
Mar 16, 2023	Statement of changes in beneficial ownership of securities	4	0001737287-23-000024.pdf 0001737287-23-000024.rtf 0001737287-23-000024.xls View HTML

Data provided by Kaleidoscope.